Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is excited to announce that SynchrogenixTM Writer is the latest Certara software to incorporate powerful deep…
Tailored biometrics capabilities that cover the full drug development continuum (pre-clinical through NDA/BLA).
Tap into knowledge of our experts who have thousands of years of combined experience across drug development.
Accelerate drug development with customized biosimulation to predict efficacy, safety, and optimal dosing strategies.
A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it helps sponsors identify and address potential Market Access, Pricing & HEOR (health economics outcomes research)…
2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus. Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication…
In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for SEND dataset review & visualizations.
© 2025 Certara. All Rights Reserved. | Privacy policy
